Table 1 Results of a literature review of 48 patients with HIV with VZV vasculopathy complicated by cerebral infarction since 2000
Characteristic | n = 48 |
|---|---|
Median age (range) | 35.5 (5–62) |
Male, n(%) | 31 (65%) |
Median CD4 count (/μL) (range) | 56.5 (1–700) |
> 200, n(%) | 6 (15%) |
\(100<\mathrm{CD}4\le\) 200, n(%) | 8 (20%) |
\(\le 1\) 00, n(%) | 26 (65%) |
Not reported, n | 8 |
The date of the previous VZV infection | |
VZV infection between 6 months and 1 year, n (%) | 3 (8%) |
On admission, n (%) | 8 (21%) |
Within 3 months, n (%) | 7 (18%) |
Between 3 and 6 months, n (%) | 3 (8%) |
No VZV infection or more than 1 year, n (%) | 18 (46%) |
Not reported, n | 9 |
Management | |
ACV + steroid clinical improvement or stable (%) | 82% |
ACV clinical improvement or stable (%) | 65% |
Duration of the treatment without death within 2 weeks, n | 4 |
3–4 weeks, n | 5 |
More than 1 month, n | 9 |
Not report treatment duration, n | 12 |
Prognosis-clinical improvement/deterioration/death/not reported, n | 27/2/10/4 |